Fused Heterocyclic Compounds as Selective BMP Inhibitors
    10.
    发明申请
    Fused Heterocyclic Compounds as Selective BMP Inhibitors 有权
    融合杂环化合物作为选择性BMP抑制剂

    公开(公告)号:US20160068525A1

    公开(公告)日:2016-03-10

    申请号:US14432472

    申请日:2013-03-15

    Abstract: The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation.

    Abstract translation: 本发明提供BMP信号传导的小分子抑制剂。 这些化合物可用于调节细胞生长,分化,增殖和凋亡,因此可用于治疗与BMP信号相关的疾病或病症,包括炎症,心血管疾病,血液病,癌症和骨骼疾病,以及 用于调节细胞分化和/或增殖。

Patent Agency Ranking